The COVID-19 Immunity Task Force (CITF) helped guide Canada’s response to the COVID-19 pandemic from April 23, 2020 until March 31, 2024.
The Secretariat is now closed.
The CITF Databank remains open.
New website: citfdatabank.ca
Email: info@citfdatabank.ca
Please send us your questions using the form or by directly emailing one of the addresses provided. We will respond as soon as possible.
General inquiries
info@covid19immunitytaskforce.ca
Media inquiries
Jean Philippe Rochette, Media Relations media@covid19immunitytaskforce.ca
Caroline Phaneuf, Communications Manager Caroline.phaneuf@mcgill.ca, +1.514.444.4532
Researcher inquiries
For questions about funding opportunities and the application process: proposals@covid19immunitytaskforce.ca
For administration of ongoing studies: admin1.citf@mcgill.ca
To submit a preprint or publication for inclusion in our Research Roundup newsletter: research@covid19immunitytaskforce.ca
Please send us your questions using the form or by directly emailing one of the addresses provided. We will respond as soon as possible.
General inquiries
info@covid19immunitytaskforce.ca
Media inquiries
media@covid19immunitytaskforce.ca
Rebecca Burns, Communications Advisor Rebecca.anne.burns@mcgill.ca, +1.438.871.8763
Caroline Phaneuf, Communications Manager Caroline.phaneuf@mcgill.ca, +1.514.444.4532
Researcher inquiries
For questions about funding opportunities and the application process: proposals@covid19immunitytaskforce.ca
For administration of ongoing studies: admin1.citf@mcgill.ca
To submit a preprint or publication for inclusion in our Research Roundup newsletter: research@covid19immunitytaskforce.ca
Mailing address and reception
The COVID-19 Immunity Task Force Secretariat is housed at the McGill University School of Population and Global Health:
Cascades Building
772 Sherbrooke Street West
3rd Floor
Montréal, QC H3A 1G1
Frequently Asked Questions
Seeking information on vaccine procurement and rollout?
The COVID-19 Vaccine Task Force advises the federal government on COVID-19 vaccine procurement and the National Advisory Committee on Immunization (NACI) advises the federal, provincial and territorial governments on vaccine delivery policy and priorities. Vaccine rollout plans are determined at the provincial level.
Seeking a test for antibodies against SARS-CoV-2, the virus that causes COVID-19?
We continue to receive requests for antibody testing from people who recall having had symptoms suggestive of COVID-19 disease but who never received a positive test for the active infection. Our mandate is to generate estimates of population level immunity, via large-scale studies. As such, we are unable to provide antibody tests to individuals. If you are interested in participating in a seroprevalence study, you may visit https://covidtrials.ca/